Serum intraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus

Mayumi Mochizuki, S. Murase, K. Takahashi, S. Shimada, H. Kume, T. Iizuka, M. Fukuda

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A patient treated with itraconazole (ITCZ) under the diagnosis of Aspergillus flavus-induced chronic hypertrophic pachymeningitis is presented. The reason for the successful cure of this patient was investigated by the pharmacokinetic analysis of serum levels of ITCZ. Concurrently administered digoxin was also investigated for its drug-drug interaction. The patient (a 75-year-old male) developed ophthalmopathy, and was diagnosed as having A. flavus hypertrophic pachymeningitis by pachymeninx biopsy. After admission, he was treated with FLCZ, AMPH, 5-FC and MCZ. The infection tended to subside with the AMPH administration. Since renal insufficiency was induced by AMPH and the other antifungal drugs were ineffective, daily administration of 200 mg of ITCZ was initiated, and the inflammatory signs and symptoms gradually subsided. The symptoms did not recur during the 36 months of intraconazole treatment after discharge, and it was concluded that ITCZ was effective for A. flavus hypertrophic pachymeningitis. Pharmacokinetic parameters of ITCZ and OH-ITCZ as follows: ITCZ: C(max) 93.2 ng/ml, T(1/2β) 11 hours, AUC0-24 999 ng · h/ml, OH- ITCZ: C(max) 159.4 ng/ml, T(1/2β) 16.2 hours, AUC0-24 of 1391 ng · h/ml. Both ITCZ and OH-ITCZ reached steady states seven days after administration began. The ITCZ and OH-ITCZ levels in serum collected 36 months after the initiation of administration were 452.9 ng/ml and 1233.6 ng/ml, respectively. C(max) and AUC0-24 of ITCZ and OH-ITCZ on the second day were markedly lower than those in healthy adults reported by Oguchi et al., and hypoalbuminemia observed at administration on that day was considered the most probable cause. It was assumed that the most plausible reason for a successful cure even at a low dose of ITCZ was the increase of distribution to tissue by the increase of the unbound form. Digoxin was concurrently given to this patient at 0.125 mg/day, but the blood digoxin level was not elevated. Consideration of the blood level of albumin is believed to be important for evaluating the blood concentration of ITCZ.

Original languageEnglish
Pages (from-to)33-39
Number of pages7
JournalJapanese Journal of Medical Mycology
Volume41
Issue number1
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Aspergillus flavus
Itraconazole
Digoxin
Serum
Meningitis
hydroxyitraconazole
Pharmacokinetics
Dura Mater
Hypoalbuminemia
Tissue Distribution

Keywords

  • Aspergillus flavus
  • Chronic hypertrophic pachymeningitis
  • Itraconazole
  • Pharmacokinetics

ASJC Scopus subject areas

  • Microbiology

Cite this

Serum intraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus. / Mochizuki, Mayumi; Murase, S.; Takahashi, K.; Shimada, S.; Kume, H.; Iizuka, T.; Fukuda, M.

In: Japanese Journal of Medical Mycology, Vol. 41, No. 1, 2000, p. 33-39.

Research output: Contribution to journalArticle

Mochizuki, Mayumi ; Murase, S. ; Takahashi, K. ; Shimada, S. ; Kume, H. ; Iizuka, T. ; Fukuda, M. / Serum intraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus. In: Japanese Journal of Medical Mycology. 2000 ; Vol. 41, No. 1. pp. 33-39.
@article{d044caa9dd2b45c88feed66de0cf3dc9,
title = "Serum intraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus",
abstract = "A patient treated with itraconazole (ITCZ) under the diagnosis of Aspergillus flavus-induced chronic hypertrophic pachymeningitis is presented. The reason for the successful cure of this patient was investigated by the pharmacokinetic analysis of serum levels of ITCZ. Concurrently administered digoxin was also investigated for its drug-drug interaction. The patient (a 75-year-old male) developed ophthalmopathy, and was diagnosed as having A. flavus hypertrophic pachymeningitis by pachymeninx biopsy. After admission, he was treated with FLCZ, AMPH, 5-FC and MCZ. The infection tended to subside with the AMPH administration. Since renal insufficiency was induced by AMPH and the other antifungal drugs were ineffective, daily administration of 200 mg of ITCZ was initiated, and the inflammatory signs and symptoms gradually subsided. The symptoms did not recur during the 36 months of intraconazole treatment after discharge, and it was concluded that ITCZ was effective for A. flavus hypertrophic pachymeningitis. Pharmacokinetic parameters of ITCZ and OH-ITCZ as follows: ITCZ: C(max) 93.2 ng/ml, T(1/2β) 11 hours, AUC0-24 999 ng · h/ml, OH- ITCZ: C(max) 159.4 ng/ml, T(1/2β) 16.2 hours, AUC0-24 of 1391 ng · h/ml. Both ITCZ and OH-ITCZ reached steady states seven days after administration began. The ITCZ and OH-ITCZ levels in serum collected 36 months after the initiation of administration were 452.9 ng/ml and 1233.6 ng/ml, respectively. C(max) and AUC0-24 of ITCZ and OH-ITCZ on the second day were markedly lower than those in healthy adults reported by Oguchi et al., and hypoalbuminemia observed at administration on that day was considered the most probable cause. It was assumed that the most plausible reason for a successful cure even at a low dose of ITCZ was the increase of distribution to tissue by the increase of the unbound form. Digoxin was concurrently given to this patient at 0.125 mg/day, but the blood digoxin level was not elevated. Consideration of the blood level of albumin is believed to be important for evaluating the blood concentration of ITCZ.",
keywords = "Aspergillus flavus, Chronic hypertrophic pachymeningitis, Itraconazole, Pharmacokinetics",
author = "Mayumi Mochizuki and S. Murase and K. Takahashi and S. Shimada and H. Kume and T. Iizuka and M. Fukuda",
year = "2000",
language = "English",
volume = "41",
pages = "33--39",
journal = "Medical mycology journal",
issn = "2185-6486",
publisher = "Japanese Society for Medical Mycology",
number = "1",

}

TY - JOUR

T1 - Serum intraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus

AU - Mochizuki, Mayumi

AU - Murase, S.

AU - Takahashi, K.

AU - Shimada, S.

AU - Kume, H.

AU - Iizuka, T.

AU - Fukuda, M.

PY - 2000

Y1 - 2000

N2 - A patient treated with itraconazole (ITCZ) under the diagnosis of Aspergillus flavus-induced chronic hypertrophic pachymeningitis is presented. The reason for the successful cure of this patient was investigated by the pharmacokinetic analysis of serum levels of ITCZ. Concurrently administered digoxin was also investigated for its drug-drug interaction. The patient (a 75-year-old male) developed ophthalmopathy, and was diagnosed as having A. flavus hypertrophic pachymeningitis by pachymeninx biopsy. After admission, he was treated with FLCZ, AMPH, 5-FC and MCZ. The infection tended to subside with the AMPH administration. Since renal insufficiency was induced by AMPH and the other antifungal drugs were ineffective, daily administration of 200 mg of ITCZ was initiated, and the inflammatory signs and symptoms gradually subsided. The symptoms did not recur during the 36 months of intraconazole treatment after discharge, and it was concluded that ITCZ was effective for A. flavus hypertrophic pachymeningitis. Pharmacokinetic parameters of ITCZ and OH-ITCZ as follows: ITCZ: C(max) 93.2 ng/ml, T(1/2β) 11 hours, AUC0-24 999 ng · h/ml, OH- ITCZ: C(max) 159.4 ng/ml, T(1/2β) 16.2 hours, AUC0-24 of 1391 ng · h/ml. Both ITCZ and OH-ITCZ reached steady states seven days after administration began. The ITCZ and OH-ITCZ levels in serum collected 36 months after the initiation of administration were 452.9 ng/ml and 1233.6 ng/ml, respectively. C(max) and AUC0-24 of ITCZ and OH-ITCZ on the second day were markedly lower than those in healthy adults reported by Oguchi et al., and hypoalbuminemia observed at administration on that day was considered the most probable cause. It was assumed that the most plausible reason for a successful cure even at a low dose of ITCZ was the increase of distribution to tissue by the increase of the unbound form. Digoxin was concurrently given to this patient at 0.125 mg/day, but the blood digoxin level was not elevated. Consideration of the blood level of albumin is believed to be important for evaluating the blood concentration of ITCZ.

AB - A patient treated with itraconazole (ITCZ) under the diagnosis of Aspergillus flavus-induced chronic hypertrophic pachymeningitis is presented. The reason for the successful cure of this patient was investigated by the pharmacokinetic analysis of serum levels of ITCZ. Concurrently administered digoxin was also investigated for its drug-drug interaction. The patient (a 75-year-old male) developed ophthalmopathy, and was diagnosed as having A. flavus hypertrophic pachymeningitis by pachymeninx biopsy. After admission, he was treated with FLCZ, AMPH, 5-FC and MCZ. The infection tended to subside with the AMPH administration. Since renal insufficiency was induced by AMPH and the other antifungal drugs were ineffective, daily administration of 200 mg of ITCZ was initiated, and the inflammatory signs and symptoms gradually subsided. The symptoms did not recur during the 36 months of intraconazole treatment after discharge, and it was concluded that ITCZ was effective for A. flavus hypertrophic pachymeningitis. Pharmacokinetic parameters of ITCZ and OH-ITCZ as follows: ITCZ: C(max) 93.2 ng/ml, T(1/2β) 11 hours, AUC0-24 999 ng · h/ml, OH- ITCZ: C(max) 159.4 ng/ml, T(1/2β) 16.2 hours, AUC0-24 of 1391 ng · h/ml. Both ITCZ and OH-ITCZ reached steady states seven days after administration began. The ITCZ and OH-ITCZ levels in serum collected 36 months after the initiation of administration were 452.9 ng/ml and 1233.6 ng/ml, respectively. C(max) and AUC0-24 of ITCZ and OH-ITCZ on the second day were markedly lower than those in healthy adults reported by Oguchi et al., and hypoalbuminemia observed at administration on that day was considered the most probable cause. It was assumed that the most plausible reason for a successful cure even at a low dose of ITCZ was the increase of distribution to tissue by the increase of the unbound form. Digoxin was concurrently given to this patient at 0.125 mg/day, but the blood digoxin level was not elevated. Consideration of the blood level of albumin is believed to be important for evaluating the blood concentration of ITCZ.

KW - Aspergillus flavus

KW - Chronic hypertrophic pachymeningitis

KW - Itraconazole

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=0034051616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034051616&partnerID=8YFLogxK

M3 - Article

C2 - 10660641

AN - SCOPUS:0034051616

VL - 41

SP - 33

EP - 39

JO - Medical mycology journal

JF - Medical mycology journal

SN - 2185-6486

IS - 1

ER -